Bernard Kerik, New York's Police Commissioner on 9/11, Dies at 69
His family said he died in a hospital, where he was being treated for heart disease. He had been hospitalized with skin cancer last year.
A cocksure high school dropout with a black belt in karate, shaved head and bulging biceps, Mr. Kerik vaulted to senior public posts as a disciple of Rudolph W. Giuliani after serving as Mr. Giuliani's bodyguard during his successful 1993 mayoral campaign.
In 1997, after Mr. Kerik had risen through the ranks of the Police Department from a street cop in Times Square and narcotics investigator, Mr. Giuliani promoted him to correction commissioner. In that position, he curbed sick-time abuse by prison guards and reduced violence by inmates.
Mr. Kerik's appointment as police commissioner in August 2000 was not well received, in part because he had been so rapidly promoted despite his lack of a college degree, which uniformed police officers ordinarily needed for promotion to captain and above. His highest rank before becoming commissioner was detective third grade. He later went on to earn a degree in 2002.
During his 16-month tenure as police commissioner, crime continued the decline that had been largely achieved by two of his predecessors, Raymond W. Kelly and William J. Bratton. Morale among officers improved. So did relations between the department and Black and Hispanic New Yorkers who had been alienated by incidents of police abuse.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
20 minutes ago
- Fast Company
Philips CEO Jeff DiLullo on how AI is changing healthcare today
AI is quietly reshaping the efficiency, power, and potential of U.S. healthcare, even as government health policy and spending drastically shift. Philips, the legacy electronics manufacturer turned medtech provider, is leading the AI healthcare revolution, streamlining and accelerating the workflow of patient care. Philips North America CEO Jeff DiLullo shares how technology can have the biggest impact on health outcomes today—from radiology scans to cancer diagnoses, and what it takes for leaders in any industry to rethink the way we work to best meet the moment. This is an abridged transcript of an interview from Rapid Response, hosted by the former editor-in-chief of Fast Company Bob Safian. From the team behind the Masters of Scale podcast, Rapid Response features candid conversations with today's top business leaders navigating real-time challenges. Subscribe to Rapid Response wherever you get your podcasts to ensure you never miss an episode. AI seems to be changing everything. There's a lot of talk about it, but in some businesses, I feel like the conversation about it is ahead of the actual implementation or the impact, and I'm curious how true that might be in medtech. How is AI impacting things now, today, versus what you think it can do in the future? If you remember, we released the Future of Health Index. One of the things that we realized is that AI, in some of these compartments I'm talking about, is quite mature. FDA cleared, very safe for clinical use. Other areas, it's more experimental. But the trust factor of the use of that AI is actually quite nascent. It's the biggest barrier right now to larger scale deployment. Yeah. That health index that you mentioned, the 2025 Future Health Index, I mean, there was this sort of trust gap in it, right? That something like 60, 65% of clinicians trust AI, but only about a third of patients or certainly older patients do. How do you bridge that gap? Is it Philips's job to bridge that gap? Whose job is it? So I have the benefit of having two Gen Zs and a millennial, they are digitally fluid. They don't worry at all about the AI models that are coming on the other side of this because they're used to it and they understand it. Older patients, not so much. The magic is always the healthcare practitioner that's directly interfacing with the customers or the patients. If they believe what they're doing, if they know it's credible, if they're using it to augment their analysis or their diagnostics, not replacing it, I think ultimately we'll see an uplift. It's our job to provide valid FDA-cleared, very good diagnostic capability leveraging AI. But if our doctors and nurses believe what we're doing and they see the value in increasing their time with patients and also a little de-stressing, we think it's going to really pick up in a parabolic way in the next few years, at least in health. I can understand and see how AI can quickly help some of the back office functionality in healthcare, but you're talking about for practitioners, right? How does that practically work today? So I'm going to give you, let's talk radiology. It's the biggest field right now, diagnostic, right? The earlier the diagnostic, the better the outcome most likely. And when I think of a radiologist, I have to wait a month and a half. I'm in a pretty nice part of Vanderbilt University area, like a lot of health tech around me in Nashville, but I've got to wait over a month to get a scan. So in radiology, we start with the box or the design, right? I have an MRI that is highly efficient. I can move it around, I can put it on a truck. But today, I can get a scan done in half or even a third of the time. The AI built into the system software makes it much faster. Just a few months ago, I had a scan that took only 20 minutes—whereas a couple of years ago, the same scan would have taken about 45 minutes. The smart speed that we have on the system actually compresses the scanning time. It doesn't fill in the blanks, it removes the noise. You actually get a better scan in a shorter time. If you're a radiologist having to do 12 or 15 studies a day, but you can do 20 studies a day, I get more patients through, I drive more reimbursement, it's better for the hospital, it's better for patient care. Then I take it into workflow, and today I can pinpoint things that are happening in that digital image and send it to a radiologist and say, 'You should look here,' in just very simple speak. It's very complicated stuff, but the AI is already mainstream today where we can actually pinpoint areas for radiologists to look at and make a determination. I can digitize the whole process today with digital pathology. And I can have a finding where somebody's waiting, do I have cancer or not? I can do this in hours now because it's all digital. And that kind of workflow and orchestration is a game changer. And the issue of AI hallucinations, which show up with some of the generative AI things, does that apply to healthcare? Are there different kinds of safeguards? Because I guess there's a human who's checking. There's so many things today, like smart speed I just talked about, being able to run that radiology workflow to compress the time of diagnostics, run the tumor boards in hours, on-demand meetings like you and I would on Zoom or teams, all of that is happening today, but not happening at the pace it could. My point is, go do that right now. Every health system, go do that. As you start to unpack these more generative AI models, I think there's real reason to be cautious and make sure we have the right controls and the governance on them, but not experimenting in them also is not an option. We kind of have to. But we see leading institutions, MGB, Stanford, Mount Sinai in New York, we see them really working with population health data to really try to train models on very specific and even broad use cases. There's so much to do right now. In other words, you don't have to go all the way out to the silver bullet of, we're going to live forever or we're going to solve every health problem. You can make the system we have right now more efficient and more effective today. Bob, when you first drove a car, was the first thing you did to go to the Autobahn? Probably not. There's so much to do in the neighborhood. There's so much to do in my town that I can really get good at what we're doing and drive productivity at scale. You need to have the innovation and the creativity to get us to the next place, but 80% of it we can do today. That is just game-changing in terms of how we deliver today, and that's what we think is really the next opportunity here for healthcare. And I think that'll happen with what's mature in AI and virtual capabilities in the next few years because the need is so great.
CBS News
21 minutes ago
- CBS News
Aurora police, ATF seize dozens of firearms and drugs, arrest TdA gang members in undercover operation
Police in Aurora, along with the ATF, DEA and several other law enforcement organizations, showed off the firearms and drugs seized in an undercover operation that resulted in the arrests of dozens of suspects. Some of those suspects have been confirmed to be TdA gang members. On Monday, the ATF displayed 69 firearms and some of the drugs seized in that operation that started 10 months ago. The undercover operation began when Arapahoe County Sheriff Tyler Brown reached out to federal agents about a spike in crime at the Ivy Crossing Apartments in Aurora. That's where, according to undercover agents, they purchased some of the drugs and guns and agents said they even discussed a possible murder-for-hire with suspects. A total of 30 people were arrested. Law enforcement said they are connected to the TdA gang in Venezuela. "We have seen an impact of what true collaboration can bring. Not only through law enforcement but through the building of trust and assurance to the residents that their safety matters," said Brown. The suspects are facing charges including federal drug trafficking, firearms offenses, and murder-for-hire. The agencies involved include the Arapahoe County Sheriff's Office, Aurora Police Department, and the City of Aurora along with the Bureau of Alcohol, Tobacco, Firearms, and Explosives, the Drug Enforcement Administration, Homeland Security Investigations, ICE Enforcement and Removal Operations, and Joint Task Force Vulcan.
Associated Press
21 minutes ago
- Associated Press
Back in the Oval Office, Zelenskyy wears a blazer and Trump doesn't shout
WASHINGTON (AP) — It was only a few months ago that U.S. President Donald Trump and Ukrainian President Volodymyr Zelenskyy last met in the Oval Office, but Monday's face-to-face between the two leaders looked markedly different. For much of their February exchange, during which Trump and Vice President JD Vance blasted Zelenskyy as 'disrespectful' and warned about future American support for his country, Zelenskyy crossed his arms and looked askance at the U.S. leaders. The presidents often spoke over each other, also gesturing disagreement. A conservative reporter, Brian Glenn, even asked Zelenskyy why he wasn't wearing a suit. Monday's meeting was rounded out with more smiles and pleasantries between Trump and Zelenskyy, as well as agreement on some points regarding Russia's ongoing war against Ukraine. Both men largely sat with their hands clasped in their laps, affably fielding questions from reporters. And Glenn, when called upon by the Republican U.S. president to speak, complimented Zelensky, saying, 'You look fabulous in that suit.' Trump chimed in right after: 'I said the same thing!'
